Mustang Bio, Inc. (MBIO) Social Stream
MUSTANG BIO INC (MBIO) Price Targets From Analysts
Use the tables below to see what analysts covering MUSTANG BIO INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-18 | 3 | $13 | $7 | $10.4 | $1.36 | 664.71% |
| 2021-11-15 | 4 | $13 | $7 | $10.4 | $1.36 | 664.71% |
| 2021-12-17 | 5 | $13 | $7 | $9.8 | $1.36 | 620.59% |
| 2022-02-18 | 5 | $11 | $6 | $8.4 | $1.36 | 517.65% |
| 2022-05-16 | 5 | $11 | $6 | $8 | $1.36 | 488.24% |
| 2022-05-19 | 4 | $8 | $6 | $7.25 | $1.36 | 433.09% |
| 2022-05-23 | 4 | $8 | $5 | $7 | $1.36 | 414.71% |
| 2022-08-12 | 4 | $8 | $4 | $6.75 | $1.36 | 396.32% |
| 2022-11-15 | 4 | $8 | $4 | $6.25 | $1.36 | 359.56% |
| 2022-11-16 | 4 | $7 | $4 | $5 | $1.36 | 267.65% |
| 2022-12-02 | 5 | $7 | $4 | $5 | $1.36 | 267.65% |
| 2023-03-30 | 4 | $104.947 | $59.97 | $78.71 | $1.36 | 5687.5% |
| 2023-03-31 | 4 | $104.947 | $59.97 | $71.214 | $1.36 | 5136.32% |
| 2023-05-15 | 4 | $104.947 | $26 | $62.721 | $1.36 | 4511.84% |
| 2023-05-22 | 4 | $59.97 | $7 | $36.235 | $1.36 | 2564.34% |
| 2023-05-23 | 4 | $59.97 | $18 | $40.735 | $1.36 | 2895.22% |
| 2023-06-12 | 4 | $59.97 | $10 | $28.242 | $1.36 | 1976.62% |
| 2023-08-15 | 4 | $25 | $10 | $17.25 | $1.36 | 1168.38% |
| 2023-11-15 | 3 | $25 | $10 | $17 | $1.36 | 1150% |
The Trend in the Analyst Price Target
Over the past 15 months, MBIO's average price target has gone up $10.75.
MBIO reports an average of 2,518.97% for its upside potential over the past 33 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-30 | 4 | 7.000 | 4.00 | 5.250 | 0.383 | 1270.76% |
| 2023-03-30 | 4 | 104.947 | 59.97 | 78.710 | 5.745 | 1270.06% |
| 2023-03-31 | 4 | 104.947 | 59.97 | 71.214 | 0.367 | 19304.36% |
| 2023-05-26 | 4 | 59.970 | 10.00 | 28.242 | 5.190 | 444.16% |
| 2023-11-15 | 3 | 25.000 | 10.00 | 17.000 | 1.600 | 962.5% |
MBIO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
MBIO's average broker recommendation rating improved by 0 over the prior 16 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- MBIO has a higher upside potential (average analyst target price relative to current price) than 2288.46% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, MUSTANG BIO INC's number of analysts covering the stock is higher than 349.54% of them.
- In the context of stocks in the small market cap category, MUSTANG BIO INC's average analyst price target is greater than 999.38% of them.
- In terms of how MUSTANG BIO INC fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -1575.5% of that group.
Stocks similar to MUSTANG BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are EOLS, ACET, and KZIA.
View All Top Stocks by Price Target
Make investment decisions regarding MBIO using the data that counts. Try POWR Ratings for free.